$INFY

Infosys Shares Drop as FY27 Revenue Forecast Cut to 1%-2% on Weak North America Demand

Infosys (INFY) cut its FY27 revenue growth forecast to 1%-2% from 1.5%-3%, citing weak North America demand. Shares fell 2.7% on the news. Q2 net income was 78.2B rupees, slightly below estimates. The company attributes the downgrade to clients reducing large IT projects.

Original reporting
Published Oct 26, 2026, 4:25 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 4:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Infosys Shares Drop as FY27 Revenue Forecast Cut to 1%-2% on Weak North America Demand — source image
Decision brief

The 30-second read

$INFYBearishMed
01

Why it matters

The guidance cut triggered a 2.7% share decline, signaling heightened risk for the sector.

02

Market read

The downgrade may prompt re‑rating of Indian IT stocks and affect related ETFs.

03

What to watch

Potential upside from cost‑optimization initiatives and upcoming fiscal year contracts not reflected in the guidance.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Infosys, a leading Indian IT outsourcer, announced a lower FY27 revenue growth outlook amid soft North America demand.

Company-level read

Ticker impact

$INFYBearishHigh confidence
Context

Infosys cut FY27 constant‑currency revenue growth to 1‑2% (down from 1.5‑3%) and shares fell 2.7% in early trade.

Expected impact

downward pressure as investors price in slower growth

Evidence & confidence

The new outlook is materially below expectations and directly caused the immediate share decline.

Market effects

Highlights a slowdown in the Indian IT services sector, potentially affecting peers like Wipro and TCS.

May weigh on broader Indian equity indices as IT is a key component.

Limited to investors with exposure to emerging‑market tech services.

Counterpoint

If the cut reflects a temporary dip and longer‑term contracts remain strong, the stock could rebound on a valuation reset.

Key entities

  • Infosys

    Indian IT services firm, ticker INFY (US ADR).

Related articles

$INFYMedAI 8/10

Infosys vs TCS: Which IT stock offers better value after Q2? Deal wins, AI growth in focus

Infosys (INFY) and TCS (TCS) reported Q2 earnings, with Infosys lowering FY27 revenue growth guidance to 1-2% and TCS maintaining stable margins at 24.0%. Infosys reported $5.2B in large-deal TCV, while TCS recorded $9.6B in deal bookings. Both companies highlighted AI revenue growth, with Infosys at 10.5% of total revenue and TCS at $3.1B annualized. Jefferies noted challenges for both, including Infosys' soft growth outlook and TCS' cost pressures.

$INFYMedAI 8/10

Infosys Share Price: Should You Buy, Sell or Hold After Q2 Results? Here’s What Brokerage has to Say

Infosys Ltd (market cap: Rs 4,60,919 crore) reported Q2 FY27 revenue growth of 1.2% QoQ, missing estimates. Brokerages like UBS, Nomura, HSBC, Goldman Sachs, and Citi have mixed outlooks, with target prices ranging from Rs 1,000 to Rs 1,415. The company cut FY27 revenue growth guidance to 1-2% YoY, citing demand challenges. Infosys' share price was Rs 1,136, down 1.62% from the previous close, with a 25% negative return over the last year.

$INFYHighAI 8/10

Infosys shares fall 4% after FY27 revenue growth guidance cut

Infosys shares dropped 4% after cutting FY27 revenue growth guidance to 1-2% from 1.5-3% due to sluggish client spending. Q2 revenue was ₹49,244 crore, up 1.5% y-o-y, with net profit increasing 6.2%. Goldman Sachs and Citi noted subdued demand and maintained neutral ratings with target prices of ₹1,000 and ₹1,105, respectively.

$INFYHighAI 8/10

Why is Infosys stock falling today?

Infosys (INFY) shares fell 1.5% after lowering its full-year revenue growth forecast to 1%–2% from 1.5%–3%, citing slower project volumes and pricing pressure. UBS cut its price target to ₹1,415 from ₹1,430, maintaining a Buy rating. Q2 revenue growth and EBIT margin missed expectations.